Research into conolidine has triggered discovery of an opioid receptor in the body referred to as ACKR3/CXCR7. ACKR3 seems to be essentially the most desired target for conolidine, which also disregards the opposite four classical opioid receptors(three). There is curiosity in employing conolidine to be a pain-reliever according to https://whatisthedrugconolidineus36802.vblogetin.com/43680084/conolidin-to-replace-traditional-painkillers-options